ATLAS (A Prospective, Multi-Center Trial of a Long-term Bio-Absorbable Mesh with Sepra Technology in Challenging Laparoscopic Ventral or Incisional Hernia Repair)
This study is enrolling patients from Proliance Surgical Specialists at Overlake located in the Overlake Medical Pavilion. The Food and Drug Administration (FDA) cleared Phasix™ ST Mesh for sale in the United States for the reinforcement of soft tissue, including hernia repair. Looking to gain further insight about the outcomes of each patient, this study follows patients for 2 years after surgery.
Kim Glorieux, CRC
Tina Fortney, RN BSN CCRC
Clinical Trial Categories